# F&M Bank Corp: overview FMBM · OTC · CIK 740806 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fmbm.md) · [Financials](/companies/fmbm/financials.md) · [Filings](/companies/fmbm/filings.md) · [Insiders](/companies/fmbm/insiders.md) Latest reported revenue: [$96.0k](/filings/0001654954-23-014253.md) for Q3 FY2023, three months to 2023-09-30, from the 10-Q filed Nov 14, 2023 (XBRL us-gaap:Revenues, accession 0001654954-23-014253). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.23](/filings/0001654954-25-012972.md) | not reported | [0.70](/filings/0001654954-26-004803.md) | [0.83](/filings/0001654954-26-007556.md) | [0.82](/filings/0001654954-25-012972.md) | not reported | [0.91](/filings/0001654954-26-004803.md) | [1.50](/filings/0001654954-26-007556.md) | | Free cash flow | $k | [1,035 d](/filings/0001654954-25-012972.md) | [3,462 d](/filings/0001654954-26-002891.md) | [5,386](/filings/0001654954-26-004803.md) | [1,893 d](/filings/0001654954-26-007556.md) | [6,922 d](/filings/0001654954-25-012972.md) | [1,578 d](/filings/0001654954-26-002891.md) | [4,968](/filings/0001654954-26-004803.md) | [4,957 d](/filings/0001654954-26-007556.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.12](/filings/0001654954-23-003359.md) | [2.41](/filings/0001654954-24-003726.md) | [0.80](/filings/0001654954-25-003506.md) | [2.07](/filings/0001654954-26-002891.md) | [3.16](/filings/0001654954-26-002891.md) | | Free cash flow | $m | [20.7](/filings/0001654954-23-003359.md) | [13.9](/filings/0001654954-24-003726.md) | [(3.3)](/filings/0001654954-25-003506.md) | [6.9](/filings/0001654954-26-002891.md) | [15.8](/filings/0001654954-26-002891.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmbm/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $4.9m | 134,364 | | Reduced −1,500 | | [PL Capital Advisors, LLC](/funds/1569147.md) | 2026-06-30 | $1.3m | 35,213 | | Added +60 | ## Recent filings [All 1,167 filings](/companies/fmbm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-28 | 16:00 ET | [8-K](/filings/0001654954-26-008611.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-008611 | | 2026-09-09 | 16:00 ET | [8-K](/filings/0001654954-26-008221.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-008221 | | 2026-08-26 | 16:17 ET | [8-K](/filings/0001654954-26-007883.md) | 5.02 Departure or appointment of officers or directors | 0001654954-26-007883 | | 2026-08-13 | 10:12 ET | [10-Q](/filings/0001654954-26-007556.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007556 | | 2026-07-30 | 14:25 ET | [8-K](/filings/0001654954-26-007023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007023 | | 2026-07-14 | 13:46 ET | [8-K](/filings/0001654954-26-006649.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-006649 | | 2026-05-27 | 16:00 ET | [8-K](/filings/0001654954-26-005428.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-005428 | | 2026-05-19 | 09:28 ET | [8-K](/filings/0001654954-26-005093.md) | 5.07 Shareholder vote results | 0001654954-26-005093 | | 2026-05-15 | 09:33 ET | [8-K](/filings/0001654954-26-004946.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-004946 | | 2026-05-13 | 11:40 ET | [10-Q](/filings/0001654954-26-004803.md) | Quarterly report, period 2026-03-31 | 0001654954-26-004803 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-002891.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 740806 - Tickers: FMBM - Exchange: OTC - SIC code: 6022 State Commercial Banks - State of incorporation: VA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 10:44 ET. No prices; not investment advice.